Applied AI Summit

Free online conference | October 14-16, 2025

Integrating Health Behaviour and AI/ML Theories: A Case for Pre-Screening Prediction in Patient Recruitment for Clinical Trials

Recruitment inefficiencies pose significant challenges for the clinical research industry, resulting in longer timelines and underpowered studies. Despite technological advancements in patient recruitment, there is still potential to optimise models by considering behavioural, social vulnerability, and time-sensitive factors. This research aims to enhance recruitment by combining behavioural theory with artificial intelligence (AI), machine learning (ML), and survival analysis.

Patient pre-screening responses were mapped to Health Belief Model (HBM) constructs using Natural Language Processing (NLP), specifically Named Entity Recognition (NER) embedded within large language models (LLMs). These behavioural features were incorporated into an XGBoost classifier to predict patient progression to the site phone screening stage. The model achieved robust performance (AUC = 0.7398; Accuracy = 67.04%), with SHAP value analysis highlighting perceived barriers and overall social vulnerability as key predictors. Constructs such as perceived severity and benefits showed more limited influence, suggesting these features may yield greater value when proactively embedded into the design of pre-screening strategies.

Survival analysis revealed a significant decline in contact probability over time, with the probability dropping below 50% by Day 11. These results highlight the need for timely patient follow-up and effective, behaviourally informed referral strategies. This research demonstrates that incorporating survival-derived probabilities into a risk-scoring framework can enhance real-world patient engagement.

This research introduces a novel, behaviourally grounded pre-screening framework that enhances the precision and adaptability of AI/ML recruitment models, thereby contributing to both the academic literature and the development of AI/ML in clinical trial recruitment.

About the speaker

Janine Zitianellis

Data Scientist, Researcher at Monarch Business School, Switzerland

Janine is a creative and passionate professional with a proven track record of delivering results. She advocates for the ethical use of data and analytics, supporting data-driven decision-making and aiming to provide business value through actionable insights. Janine possesses a broad range of skills and deep expertise in advanced analytics, machine learning, data mining methodologies, data quality, and visualisation. Her successful career spans several industries, including pharmaceuticals and biotechnology, banking, credit and collections, retail, and manufacturing. In addition to her enthusiasm for data science, Janine is deeply committed to giving back to her community. She actively supports multiple initiatives, including Friends of Care Animal Welfare, and serves as an ambassador for The Warrior Project—an organisation focused on combating gender-based violence. Janine holds a master’s degree in data analytics and operations management from Arden University and has completed a postgraduate programme in data science and business analytics at the McCombs School of Business at the University of Texas. Currently, she is pursuing a PhD at Monarch Business School in Switzerland.